Lv2
150 积分 2023-01-10 加入
Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial
25天前
已完结
Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial
25天前
已完结
High concentration subcutaneous biological drug products: challenges and advancements
29天前
已完结
Subcutaneous blinatumomab in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: post-hoc safety and activity analysis from a multicentre, single-arm, phase 1/2 trial
29天前
已完结
TTF-1 expression in lung adenocarcinoma: clinicopathologic, genomic, and immunophenotypic correlates and outcomes to immunotherapy-based treatments and KRASG12C inhibitors
2个月前
已关闭
Global trends in melanoma burden: A comprehensive analysis from the Global Burden of Disease Study, 1990-2021
2个月前
已完结
Immunogenicity and safety of the 9-valent HPV vaccine in men
2个月前
已完结
Global Burden of Penile Cancer: A Review of Health Disparities for a Rare Disease
2个月前
已完结
Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature
3个月前
已完结
皖公网安备34019202002308
